Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.62 |
| ▸ | TUBB4A | P04350 | 6/20 | 0.61 |
| ▸ | TUBB | P07437 | 6/20 | 0.61 |
| ▸ | TUBA3C | P0DPH7 | 6/20 | 0.61 |
| ▸ | TUBA1B | P68363 | 6/20 | 0.61 |
| ▸ | TUBA4A | P68366 | 6/20 | 0.61 |
| ▸ | TUBB4B | P68371 | 6/20 | 0.61 |
| ▸ | TUBB3 | Q13509 | 6/20 | 0.61 |
| ▸ | TUBB2A | Q13885 | 6/20 | 0.61 |
| ▸ | TUBB8 | Q3ZCM7 | 6/20 | 0.61 |
| ▸ | TUBA3E | Q6PEY2 | 6/20 | 0.61 |
| ▸ | TUBA1A | Q71U36 | 6/20 | 0.61 |
| ▸ | TUBA1C | Q9BQE3 | 6/20 | 0.61 |
| ▸ | TUBB6 | Q9BUF5 | 6/20 | 0.61 |
| ▸ | TUBB2B | Q9BVA1 | 6/20 | 0.61 |
| ▸ | TUBB1 | Q9H4B7 | 6/20 | 0.61 |
| ▸ | NR0B1 | P51843 | 1/20 | 0.58 |
| ▸ | XDH | P47989 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17938762 | 0.92 | XDH (0.69) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL38664093 | 0.92 | XDH (0.69) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL29649084 | 0.82 | TUBB4A (0.86) | ABCG2TUBB4ATUBBTUBA3CTUBA1B | |
| Chrysosplenol B SCHEMBL29558792 | 0.82 | ABCG2 (0.78) | ABCG2TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL13560795 | 0.82 | TUBB4A (0.86) | ABCG2TUBB4ATUBBTUBA3CTUBA1B | |
| Chrysosplenol C SCHEMBL4742072 | 0.82 | ABCG2 (0.73) | ABCG2TUBB4ATUBBTUBA3CTUBA1B | |
| Chrysosplenol B SCHEMBL2369883 | 0.82 | ABCG2 (0.78) | ABCG2TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL29696493 | 0.80 | UGT1A1 (0.69) | MEN1KMT2AMAPTPOLBABCB1 | |
| SCHEMBL9063795 | 0.80 | ABCB1 (0.70) | ABCG2TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL19461023 | 0.80 | MAPT (0.60) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250051551-A1 | IMPROVED POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2025-02-13 | — | — | US | claimed |
| US-20090246293-A1 | COMPOSITIONS AND METHODS TO CONTROL OOMYCETE FUNGAL PATHOGENS | DOW AGROSCIENCES LLC (US) | 2009-10-01 | — | — | US | claimed |
| US-12569530-B2 | Tannin-based antiproliferative pharmaceutical | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2026-03-10 | — | — | US | disclosed |
| US-12453799-B1 | Bioadhesive for medical and dental applications | IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) | 2025-10-28 | — | — | US | disclosed |
| US-20250249063-A1 | METHOD FOR TREATING ORAL CANCER | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2025-08-07 | — | — | US | disclosed |
| US-12318422-B2 | Tannin-based antiproliferative pharmaceutical | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2025-06-03 | — | — | US | disclosed |
| WO-2025049925-A2 | LIPIDOID COMPOUNDS AND RELATED COMPOSITIONS AND USES | POSEIDA THERAPEUTICS, INC. (US) | 2025-03-06 | — | — | WO | disclosed |
| US-20250051551-A1 | IMPROVED POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2025-02-13 | — | — | US | disclosed |
| US-12163004-B2 | Polymer composites | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2024-12-10 | — | — | US | disclosed |
| US-20240355451-A1 | METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY | NESTLE SA (CH) | 2024-10-24 | — | — | US | disclosed |
| US-20240293492-A1 | TANNIN-BASED ANTIPROLIFERATIVE PHARMACEUTICAL | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2024-09-05 | — | — | US | disclosed |
| WO-2016122889-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | KALEIDO BIOSCIENCES, INC. (US) | 2016-08-04 | — | — | WO | disclosed |
| US-8664185-B2 | Method for preparing polyphenol extracts from spinach leaves | NATUREX (FR) | 2014-03-04 | — | — | US | disclosed |
| EP-2488021-A1 | COMPOSITIONS AND METHODS TO CONTROL OOMYCETE FUNGAL PATHOGENS | Dow AgroSciences LLC (US) | 2012-08-22 | — | — | EP | disclosed |
| US-20120196818-A1 | METHOD FOR PREPARING POLYPHENOL EXTRACTS FROM SPINACH LEAVES | BURGUNDY (FR) | 2012-08-02 | — | — | US | disclosed |
| WO-2011047025-A1 | COMPOSITIONS AND METHODS TO CONTROL OOMYCETE FUNGAL PATHOGENS | DOW AGROSCIENCES LLC (US) | 2011-04-21 | — | — | WO | disclosed |
| US-20110086761-A1 | COMPOSITIONS AND METHODS TO CONTROL OOMYCETE FUNGAL PATHOGENS | DOW AGROSCIENCES LLC (US) | 2011-04-14 | — | — | US | disclosed |
| EP-2278882-A2 | COMPOSITIONS AND METHODS TO CONTROL OOMYCETE FUNGAL PATHOGENS | Dow AgroSciences LLC (US) | 2011-02-02 | — | — | EP | disclosed |
| WO-2009146079-A2 | COMPOSITIONS AND METHODS TO CONTROL OOMYCETE FUNGAL PATHOGENS | DOW AGROSCIENCES LLC (US) | 2009-12-03 | — | — | WO | disclosed |
| US-20090246293-A1 | COMPOSITIONS AND METHODS TO CONTROL OOMYCETE FUNGAL PATHOGENS | DOW AGROSCIENCES LLC (US) | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250249063-A1 | METHOD FOR TREATING ORAL CANCER | UGGT1, G6PD, UGT1A3 | ABCG2 382/4885TUBB4A 192/4885TUBB 436/4885 |
| US-20240293492-A1 | TANNIN-BASED ANTIPROLIFERATIVE PHARMACEUTICAL | UGGT1, G6PD, UGDH | ABCG2 144/4885TUBB4A 323/4885TUBB 566/4885 |
| US-20090246293-A1 | COMPOSITIONS AND METHODS TO CONTROL OOMYCETE FUNGAL PATHOGENS | ERG28, DPM1, CYP51A1 | ABCG2 2937/4885TUBB4A 328/4885TUBB 225/4885 |
| US-12569530-B2 | Tannin-based antiproliferative pharmaceutical | SLC2A3, SLC2A1, SLC2A8 | ABCG2 129/4885TUBB4A 505/4885TUBB 506/4885 |
| US-20110086761-A1 | COMPOSITIONS AND METHODS TO CONTROL OOMYCETE FUNGAL PATHOGENS | ERG28, DPM1, BROX | ABCG2 4115/4885TUBB4A 266/4885TUBB 123/4885 |
| US-12318422-B2 | Tannin-based antiproliferative pharmaceutical | UGGT1, G6PD, UGDH | ABCG2 144/4885TUBB4A 323/4885TUBB 566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.